Weight gain and height velocity in young children 1 year following bone marrow transplant: a single institution study

Cheryl Rodgers1

  • 1Baylor College of Medicine, Texas Children's Cancer Center, Texas Children's Hospital, Houston, USA. ccrodger@texaschildrenshospital.org

Insights

Children undergoing bone marrow transplant (BMT) showed variable growth. Graft-versus-host disease negatively impacted weight and height gain in pediatric BMT patients, highlighting the need for nutritional monitoring.

Area of Science:

  • Pediatric Hematology/Oncology
  • Clinical Nutrition
  • Transplant Medicine

Background:

  • Nutritional and growth outcomes in pediatric patients post-bone marrow transplant (BMT) are not well-documented.
  • Understanding these effects is crucial for optimizing patient recovery and long-term health.

Purpose of the Study:

  • To describe the growth patterns of young children during the first year following an allogeneic bone marrow transplant.
  • To identify factors influencing growth in this vulnerable pediatric population.

Main Methods:

  • Retrospective chart review of 25 pediatric patients (1-6 years old) who received an allogeneic BMT.
  • Nutritional data collected pre-BMT and at 3, 6, 9, and 12 months post-BMT.

Main Results:

  • Mean weight gain was 2.5 kg (median 2.3 kg); mean height gain was 7 cm (median 7.4 cm).
  • Growth was comparable across gender, age, and infection incidence.
  • Children with graft-versus-host disease exhibited significantly poorer weight and height gain.

Conclusions:

  • Pediatric BMT patients experience varied growth post-transplant.
  • Graft-versus-host disease is a significant risk factor for impaired growth.
  • Nurses play a vital role in identifying and managing nutritional risks in pediatric BMT patients.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...